MEA C-Arms Market

MEA C-Arms Market Size & Growth (2023 to 2028):

As per the research report, the size of the Middle East and Africa C-Arms Market is valued at USD 0.15 billion in 2022 and estimated to be growing at a CAGR of 2.96%, to reach USD 0.18 billion by 2028 during the forecast period 2023 to 2028.

MARKET DRIVERS

An image scanner intensifier is known as a C-arm. It is based on X-ray technology and is commonly utilized in clinics and hospitals' operating rooms. The MEA C-Arms is expected to be driven by the factors such as the increasing incidence of chronic diseases, including cancer, diabetes, arthritis, obesity, and heart attack. In addition, the market growth is influenced by the technological advancements in the healthcare sector in the region. The market for C-Arms is expected to expand faster as the popularity of minimally invasive treatments grows. According to Farah Naja in a 2019 article, the Middle East is experiencing rising obesity rates, with eight of its nations ranking among the highest globally for obesity prevalence among persons aged 18 and above. However, increasing in the geriatric population is most likely to augment the market growth. Middle East Africa is witnessing an increase in the geriatric population since senior people are more prone to cancer and the prevalence of diseases. New product launches, new product approvals, geographic expansion in the market, and strategic decisions are major factors expected to drive the C-Arms Market during the forecast period. In addition, favorable market regulations and the presence of significant market players are propelling the market.

Furthermore, increasing investment and funding by the government in developing countries encourage market growth. Over the years, breast cancer is the most common disease in this region, and the average age of diagnosis is a decade younger than in Western nations. These factors increase the demand for operations and the usage of C-arms in healthcare institutions. With the growing popularity of portable C-arms, there is a significant market potential for manufacturers of tiny C-arms. Several micro c-arms are intended explicitly for extremities imaging, and they have a smaller footprint and more mobility than full-size c-arms.

MARKET RESTRAINTS

However, constraints such as a shortage of qualified specialists, growing cost concerns, and a lack of policy uniformity and synchronisation are limiting the market's growth in this region.

This research report segmented and sub-segmented into the following categories:

By Device type: 

• Fixed C-Arms
• Mobile C-Arms
  • Mini C-Arms
  • Full-Size C-Arms

By Application:

• Cardiovascular
• Neurology
• Urology
• Orthopaedic
• Pain Management and Trauma
• Gastrointestinal
• General Surgery

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

REGIONAL ANALYSIS

The MEA C-Arms Market is one of the growing markets over the forecast period. The market is growing is driven by the presence of major market players and technological advancements healthcare sector in the region. Manufacturers distinguish their products based on mobility, the field of vision, and the inclusion of alternative imaging technologies.

However, joint ventures are progressively growing in nations like South Africa and the United Arab Emirates, which is likely to increase demand for micro c-arm imports and installations across the region. South Africa, UAE, Saudi Arabia is the fastest-growing regions in the MEA over the years.  The United Arab Emirates is expected to have the highest share in the market and contribute to the regional market in the forecast period. The presence of advanced healthcare infrastructure, increasing healthcare spending, and favorable government reimbursement programs are driving the market growth in the country.

Companies leading in the MEA C-Arms Market profiled in the report are GE Healthcare Inc., Varian Medical Systems Inc., Philips Healthcare, Siemens AG, Toshiba Corp., Hologic corp., Omega Medical Imaging Inc., BMI Biomedical International, Hitachi Ltd., DMS Health Technologies, ATON GmbH, Medonica Co Ltd., Gemss Co Ltd., and Shimadzu Corp.